NCT04624256 2026-03-13
GARUDA
Jonsson Comprehensive Cancer Center
Phase NA Active not recruiting
Clinical Trials
89 trialsNCT06523634 2026-03-12
STEREOBED
Jules Bordet Institute
Phase NA Recruiting
NCT07451795 2026-03-05
SHARP
Fudan University
Phase 2 Recruiting
NCT03159676 2026-02-25
Proton-Based Stereotactic Ablative Body Radiotherapy for Prostate Cancer
Mayo Clinic
Completed
NCT07426055 2026-02-23
PRO-BOOST-LC
Affidea Nu-med Center of Oncological DIagnostics and Therapy
Phase 2/3 Not yet recruiting
NCT05320406 2026-02-12
REVELUTION
Emory University
Phase 2 Active not recruiting
NCT07393867 2026-02-06
ARPEGGIO
Brigham and Women's Hospital
Phase 2 Not yet recruiting
NCT03902951 2026-02-05
Antiandrogen Therapy and SBRT in Treating Patients With Recurrent, Metastatic Prostate Cancer
Jonsson Comprehensive Cancer Center
Phase 2 Active not recruiting
NCT02016248 2026-02-02
SBRT Boost for Unfavorable Prostate Cancer'
MemorialCare Health System
Phase NA Recruiting
NCT05946213 2026-02-02
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
NRG Oncology
Phase 3 Recruiting
NCT03796767 2026-01-28
SOAR
University of Utah
Phase 2 Active not recruiting
NCT06397703 2026-01-28
ADT and SBRT vs SBRT Alone for Unfavorable Intermediate Risk Prostate Cancer
NYU Langone Health
Phase 2 Recruiting
NCT06205316 2026-01-20
SBRT Versus Hypofractionated Radiotherapy for Biochemically Recurrent or Oligometastatic Prostate Adenocarcinoma
Mayo Clinic
Phase 3 Recruiting
NCT05038332 2026-01-16
Post-prostatectomy Radiation Therapy--Moderate Versus Ultra-hypofractionated (Also Known as Stereotactic Body Radiation Therapy [SBRT])
University of Michigan Rogel Cancer Center
Phase 2 Recruiting
NCT05053152 2026-01-14
Testing the Addition of the Drug Relugolix to the Usual Radiation Therapy for Advanced-Stage Prostate Cancer, The NRG Promethean Study
NRG Oncology
Phase 2 Recruiting
NCT06378866 2025-12-26
DIVINE
Mayo Clinic
Phase 2 Recruiting
NCT03007732 2025-12-05
Pembrolizumab +/- SD-101 in Hormone-Naïve Oligometastatic Prostate Cancer With RT and iADT
University of California, San Francisco
Phase 2 Completed
NCT05893381 2025-12-03
LUST
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Phase 2 Recruiting
NCT03436654 2025-11-28
Multi-arm Multi-modality Therapy for Very High Risk Localized and Low Volume Metastatic Prostatic Adenocarcinoma
Memorial Sloan Kettering Cancer Center
Phase 2 Active not recruiting
NCT01923506 2025-11-26
Stereotactic Body Radiation Therapy in Treating Patients With Prostate Cancer After Undergoing Surgery
City of Hope Medical Center
Phase 1 Active not recruiting
NCT05079698 2025-11-10
A Study of Stereotactic Body Radiotherapy and 177Lu-PSMA-617 for the Treatment of Prostate Cancer
Memorial Sloan Kettering Cancer Center
Phase 1 Recruiting
NCT07219303 2025-10-29
DE-CART
Fox Chase Cancer Center
Phase NA Recruiting
NCT04693377 2025-10-27
Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME Trial
M.D. Anderson Cancer Center
Phase NA Recruiting
NCT06325046 2025-10-16
Adaptive Radiation Therapy (ART) Stereotactic Ablative Body Radiotherapy (SABR) for Primary Localized Prostate Cancer
Mayo Clinic
Phase NA Recruiting
NCT07189598 2025-09-24
ORION
Center Eugene Marquis
Phase NA Not yet recruiting
NCT02170181 2025-09-17
Clinical Registry for Oligometastic Disease, Consolidation Therapy, Debulking Prior to Chemotherapy, or Re-Irradiation
University of Texas Southwestern Medical Center
Completed
NCT03889119 2025-09-15
Stereotactic Body Radiation Therapy (SBRT) for Prostate Cancer
Hoag Memorial Hospital Presbyterian
Phase NA Active not recruiting
NCT01655836 2025-09-11
High-Dose Rate Brachytherapy and Stereotactic Body Radiation Therapy in Treating Patients With Prostate Cancer
Thomas Jefferson University
Phase 1 Active not recruiting
NCT07152067 2025-09-03
TOPPGUN-RS
Centre Hospitalier Universitaire de Liege
Phase 2 Not yet recruiting
NCT07132073 2025-08-27
MRI-guided Locoregional SBRT Prostate Program
Clinica Universidad de Navarra, Universidad de Navarra
Phase NA Not yet recruiting
NCT04552509 2025-07-22
TRUEBEAM Stereotactic Body Radiotherapy for Localized Prostate Cancer
MemorialCare Health System
Phase NA Recruiting
NCT04945642 2025-07-15
HYDRA
Jonsson Comprehensive Cancer Center
Phase NA Recruiting
NCT01508390 2025-06-26
Hypofractionated Stereotactic Body Radiation Therapy as a Boost to the Prostate
Boston Medical Center
Phase NA Active not recruiting
NCT04004312 2025-06-25
Single Fractions SBRT for Prostate Cancer
McGill University Health Centre/Research Institute of the McGill University Health Centre
Phase NA Recruiting
NCT04915508 2025-06-22
EXCALIBUR
Jonsson Comprehensive Cancer Center
Phase 2 Recruiting
NCT06546267 2025-06-11
PROST-ART
IRCCS San Raffaele
Recruiting
NCT04194554 2025-06-04
ASCLEPIuS
University of Michigan Rogel Cancer Center
Phase 1/2 Active not recruiting
NCT05830838 2025-05-21
DAPPER
Mayo Clinic
Phase NA Active not recruiting
NCT04848909 2025-05-15
PLUTO-MPC
Sunnybrook Health Sciences Centre
Phase NA Active not recruiting
NCT05496959 2025-05-13
LUNAR
Jonsson Comprehensive Cancer Center
Phase 2 Active not recruiting
NCT05169970 2025-05-08
A Study of Stereotactic Body Radiation Therapy (SBRT) Without Androgen Deprivation Therapy (ADT) in People With Unfavorable Intermediate-Risk Prostate Cancer
Memorial Sloan Kettering Cancer Center
Phase 2 Recruiting
NCT03477864 2025-04-29
Stereotactic Body Radiation Therapy With REGN2810 and/or Ipilimumab Before Surgery in Treating Participants With Progressive Advanced or Oligometastatic Prostate Cancer
Thomas Jefferson University
Phase 1 Withdrawn
NCT04262154 2025-04-27
Study of Abiraterone Acetate or Enzalutamide, Atezolizumab, GnRH Analog and Radiation Therapy in Men With Newly Diagnosed Hormone-sensitive Prostate Cancer
Memorial Sloan Kettering Cancer Center
Phase 2 Active not recruiting
NCT05224869 2025-02-26
Rectal Spacer Hydrogel Before Radiation Therapy in Reducing Radiation Dose to the Rectum in Patients With Prostate Cancer
Icahn School of Medicine at Mount Sinai
Phase NA Terminated
NCT06665932 2024-11-12
Stereotactic Radiotherapy of Prostate Cancer With Reduction of Safety Margins
University Hospital Ostrava
Phase NA Recruiting
NCT05655715 2024-10-16
CheckPRO
Herlev and Gentofte Hospital
Phase 2 Completed
NCT01985828 2024-10-03
CyberKnife® as Monotherapy or Boost SBRT for Intermediate or High Risk Localized Prostate Cancer
Wake Forest University Health Sciences
Phase NA Completed
NCT03056638 2024-08-28
Trial of ADT and SBRT Versus SBRT for Intermediate Prostate Cancer
Memorial Sloan Kettering Cancer Center
Phase 3 Terminated
NCT05352178 2024-07-03
SPARKLE
Universitaire Ziekenhuizen KU Leuven
Phase 3 Recruiting
NCT04571762 2024-05-23
Adaptive MR-guided SBRT for Localized Prostate Cancer
University of Zurich
Phase NA Not yet recruiting